AxoGen, Inc.AXGNNASDAQ
LOADING
|||
Switch Symbol:
R&D Expense Growth Under Pressure
Trending lower, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
10.39%
↑ 79% above average
Average (39q)
5.81%
Historical baseline
Range
High:27.14%
Low:-11.77%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 10.39% |
| Q2 2025 | 12.51% |
| Q1 2025 | -9.51% |
| Q4 2024 | -3.79% |
| Q3 2024 | 5.08% |
| Q2 2024 | -10.14% |
| Q1 2024 | 1.48% |
| Q4 2023 | 9.07% |
| Q3 2023 | -6.30% |
| Q2 2023 | 6.96% |
| Q1 2023 | -1.94% |
| Q4 2022 | -3.39% |
| Q3 2022 | 0.40% |
| Q2 2022 | 11.90% |
| Q1 2022 | -0.43% |
| Q4 2021 | -1.59% |
| Q3 2021 | 11.90% |
| Q2 2021 | -0.43% |
| Q1 2021 | 16.57% |
| Q4 2020 | 16.57% |
| Q3 2020 | 3.91% |
| Q2 2020 | -11.77% |
| Q1 2020 | -6.07% |
| Q4 2019 | 17.48% |
| Q3 2019 | -2.36% |
| Q2 2019 | 3.45% |
| Q1 2019 | 8.72% |
| Q4 2018 | 15.12% |
| Q3 2018 | 27.14% |
| Q2 2018 | 26.38% |
| Q1 2018 | 4.36% |
| Q4 2017 | 9.86% |
| Q3 2017 | 18.01% |
| Q2 2017 | 7.80% |
| Q1 2017 | 19.68% |
| Q4 2016 | 5.46% |
| Q3 2016 | 19.34% |
| Q2 2016 | -4.24% |
| Q1 2016 | 9.47% |
| Q4 2015 | -4.52% |